Reactions 1704, p287 - 2 Jun 2018 Falling asleep: case report A 32-year-old man experienced falling asleep during treatment with risperidone and olanzapine for schizophrenia. The man travelled to Canada to his family. During his stay, he experienced a nervous breakdown and hence returned to Poland. However, due to weird behaviour and psychomotor agitation in the plane, he was detained at the Warsaw airport and admitted to a psychiatric hospital for a week. Eight months later, his illness recurred and was forcibly taken to a psychiatric department. During both the hospitalisations, he was diagnosed with schizophrenia, and was recommended treatment with olanzapine and risperidone. Two months later, he discontinued the treatment as he claimed that the treatment made him fell asleep [time to reaction onset and outcome not stated]. Author comment: "[H]e was diagnosed with schizophrenia and it was recommended that he be treated with olanzapine and risperidone. After two-month treatment, he discontinued his medicine, since, as he claimed, it had made him fell asleep". Dziurkowski M, et al. Public perception of a dangerous person in psychotic exacerbation on the example of a court expert judgement case. Postepy Psychiatrii i Neurologii 26: 36-43, No. 1, Jan 2017. Available from: URL: http:// doi.org/10.5114/ppn.2017.68293 - Poland 803323628 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera